InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,191.20
(
-0.44%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
87.13
(
0.69%
)
Bitcoin
62,541.92
(
-0.49%
)
Post# of 252455
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119964
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 76098

Friday, 05/15/2009 8:08:08 AM

Friday, May 15, 2009 8:08:08 AM

Post# of 252455
GILD Dumps ACH-1095—ACHN Stunned

The zinger is buried within the PR for the 1Q09 financial results:

http://finance.yahoo.com/news/Achillion-Reports-First-pz-15255653.html

Achillion and Gilead have arrived at different opinions on the appropriate further progression of ACH-1095 [a/k/a/ GS 9525], based on their respective scientific assessments of the therapeutic index for ACH-1095 from various preclinical studies. Gilead indicated that it does not intend to initiate clinical development of GS 9525, while Achillion believes that the compound should be advanced.

As of 3/3/109, ACHN had $27.1M of cash; it looks like they will need all of it.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up